Although knowledge on somatic landscape of MBC is increasing, comprehension on the role of somatic alterations of specific genes with potential prognostic and therapeutic significance need to be further investigated in MBCs characterized for BRCA1/2 mutations. This evidence concerns the gene BRCA1 and maternal uniparental disomy of chromosome 20.